Recurrent Episodes of Hypokalaemia during Treatment with Inhaled Beta-2 Agonist Revealing Gitelman Syndrome, an Uncommon Clinical Entity

A 28-year-old female patient was hospitalized for mild–moderate hypokalaemia which was persistent despite discontinuation of beta-2 agonist bronchodilator treatment. Her past medical history was relevant for two episodes of severe hypokalaemia after active inhaled beta-2 agonist treatment for asthma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sablón-González, Nery, Parodis-López, Yanet, Alonso-Ortiz, Maria Belen, Laurin, Angélica, Andrès, Emmanuel, Lorenzo-Villalba, Noel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678125/
https://www.ncbi.nlm.nih.gov/pubmed/36415838
http://dx.doi.org/10.12890/2022_003605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678125/
https://www.ncbi.nlm.nih.gov/pubmed/36415838
http://dx.doi.org/10.12890/2022_003605

Ejemplares similares